UB Paderborn / Katalog / Suche / in CDI

4CPS-371 Usability evaluation of a personalised health record for detecting medication discrepancies

European journal of hospital pharmacy. Science and practice, 2021-03, Vol.28 (Suppl 1), p.A99-A99

2021

Link zum Volltext

Verfügbarkeit prüfen

Actual versus recommended storage temperatures of oral anticancer medicines at patients’ homes

Journal of oncology pharmacy practice, 2019-03, Vol.25 (2), p.382-389

2019

Link zum Volltext

Verfügbarkeit prüfen

Disease activity guided dose reduction and withdrawal of adalimumab or etanercept compared with usual care in rheumatoid arthritis: open label, randomised controlled, non-inferiority trial

BMJ (Online), 2015-04, Vol.350, p.h1389

2015

Link zum Volltext

Verfügbarkeit prüfen

Down-titration and discontinuation strategies of tumor necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity

Cochrane database of systematic reviews, 2014-09 (9), p.CD010455-CD010455

2014

Link zum Volltext

Verfügbarkeit prüfen

Disease activity-guided dose optimisation of adalimumab and etanercept is a cost-effective strategy compared with non-tapering tight control rheumatoid arthritis care: analyses of the DRESS study

Annals of the rheumatic diseases, 2016-11, Vol.75 (11), p.1939-1944

2016

Link zum Volltext

Verfügbarkeit prüfen

Prediction of successful dose reduction or discontinuation of adalimumab, etanercept, or infliximab in rheumatoid arthritis patients using serum drug levels and antidrug antibody measurement

Expert opinion on drug metabolism & toxicology, 2017-06, Vol.13 (6), p.597-604

2017

Link zum Volltext

Verfügbarkeit prüfen

Adalimumab and etanercept serum (anti)drug levels are not predictive for successful dose reduction or discontinuation in rheumatoid arthritis

Annals of the rheumatic diseases, 2015-12, Vol.74 (12), p.2260-2261

2015

Link zum Volltext

Verfügbarkeit prüfen

Preferences of patients with rheumatoid arthritis regarding disease-modifying antirheumatic drugs: a discrete choice experiment

Patient preference and adherence, 2019-07, Vol.13, p.1199-1211

2019

Link zum Volltext

Verfügbarkeit prüfen

Dose REduction strategy of subcutaneous TNF inhibitors in rheumatoid arthritis: design of a pragmatic randomised non inferiority trial, the DRESS study

BMC musculoskeletal disorders, 2013-10, Vol.14 (1), p.299-299, Article 299

2013

Link zum Volltext

Verfügbarkeit prüfen

Associations between personality traits and adequate home storage of drugs in older patients

Psychology, health & medicine, 2019-11, Vol.24 (10), p.1255-1266

2019

Link zum Volltext

Verfügbarkeit prüfen

4CPS-352 Patients in charge: why we should implement an online personal health record as a tool for medication reconciliation

European journal of hospital pharmacy. Science and practice, 2021, Vol.28 (Suppl 1), p.A90-A90

2021

Link zum Volltext

Verfügbarkeit prüfen

Dose reduction of tocilizumab in rheumatoid arthritis patients with low disease activity

Clinical and experimental rheumatology, 2014-05, Vol.32 (3), p.390

2014

Link zum Volltext

Verfügbarkeit prüfen

A discrete choice experiment on preferences of patients with rheumatoid arthritis regarding disease-modifying antirheumatic drugs: the identification, refinement, and selection of attributes and levels

Patient preference and adherence, 2018-01, Vol.12, p.1537-1555

2018

Link zum Volltext

Verfügbarkeit prüfen

Support needs for medication use and the suitability of eHealth technologies to address these needs: a focus group study of older patients with rheumatoid arthritis

Patient preference and adherence, 2018-01, Vol.12, p.349-358

2018

Link zum Volltext

Verfügbarkeit prüfen

Intradermal influenza vaccination in immunocompromized patients is immunogenic and feasible

Vaccine, 2009-04, Vol.27 (18), p.2469-2474

2009

Link zum Volltext

Verfügbarkeit prüfen

Making the rheumatologist aware of patients' non-adherence does not improve medication adherence in patients with rheumatoid arthritis

Scandinavian journal of rheumatology, 2011-05, Vol.40 (3), p.192-196

2011

Link zum Volltext

Verfügbarkeit prüfen

Can response duration after the first rituximab treatment be used in timing of rituximab retreatment?

Scandinavian journal of rheumatology, 2013-01, Vol.42 (3), p.251-252

2013

Link zum Volltext

Verfügbarkeit prüfen

Dose Reduction Of Tocilizumab In Rheumatoid Arthritis Patients With Low Disease Activity Is Feasible

ARTHRITIS AND RHEUMATISM, 2013, Vol.65, p.S992

2013

Link zum Volltext

Verfügbarkeit prüfen

Pharmaceutical development of a parenteral formulation of the investigational anticancer drug clanfenur

PDA journal of pharmaceutical science and technology, 1997-03, Vol.51 (2), p.89

1997

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

4CPS-371 Usability evaluation of a personalised health record for detecting medication discrepancies

Actual versus recommended storage temperatures of oral anticancer medicines at patients’ homes

Disease activity guided dose reduction and withdrawal of adalimumab or etanercept compared with usual care in rheumatoid arthritis: open label, randomised controlled, non-inferiority trial

Down-titration and discontinuation strategies of tumor necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity

Disease activity-guided dose optimisation of adalimumab and etanercept is a cost-effective strategy compared with non-tapering tight control rheumatoid arthritis care: analyses of the DRESS study

Prediction of successful dose reduction or discontinuation of adalimumab, etanercept, or infliximab in rheumatoid arthritis patients using serum drug levels and antidrug antibody measurement

Adalimumab and etanercept serum (anti)drug levels are not predictive for successful dose reduction or discontinuation in rheumatoid arthritis

Preferences of patients with rheumatoid arthritis regarding disease-modifying antirheumatic drugs: a discrete choice experiment

Dose REduction strategy of subcutaneous TNF inhibitors in rheumatoid arthritis: design of a pragmatic randomised non inferiority trial, the DRESS study

Associations between personality traits and adequate home storage of drugs in older patients

4CPS-352 Patients in charge: why we should implement an online personal health record as a tool for medication reconciliation

Dose reduction of tocilizumab in rheumatoid arthritis patients with low disease activity

A discrete choice experiment on preferences of patients with rheumatoid arthritis regarding disease-modifying antirheumatic drugs: the identification, refinement, and selection of attributes and levels

Support needs for medication use and the suitability of eHealth technologies to address these needs: a focus group study of older patients with rheumatoid arthritis

Intradermal influenza vaccination in immunocompromized patients is immunogenic and feasible

Making the rheumatologist aware of patients' non-adherence does not improve medication adherence in patients with rheumatoid arthritis

Can response duration after the first rituximab treatment be used in timing of rituximab retreatment?

Dose Reduction Of Tocilizumab In Rheumatoid Arthritis Patients With Low Disease Activity Is Feasible

Pharmaceutical development of a parenteral formulation of the investigational anticancer drug clanfenur

Suchergebnisse filtern